William Burke
Geriatric Psychiatry · Omaha, NENPI 1487691663
Payments from drug & device makers
Across 47 payments — averaging $39,820 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$693K
- Eli Lilly$489K
- Biogen$381K
- AbbVie$270K
- Janssen Research & Development, LLC$22K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$11K
- plus $5K from 1 others
Across 1 payment — averaging $2500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3K
What the payments were for
- Consulting fees$19,72592%
- Travel & lodging$1,3246%
- Food & beverage$3522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 5 | $693,401 |
| Eli Lilly | 9 | $489,125 |
| Biogen | 14 | $380,709 |
| AbbVie | 9 | $269,749 |
| Janssen Research & Development, LLC | 1 | $22,371 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $11,200 |
| Eisai Inc. | 5 | $4,973 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$11,200
How this compares
Too few geriatric psychiatry providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Other geriatric psychiatry in Omaha
- Steven WengelOmaha$0
- Thomas MagnusonOmaha$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.